Suppr超能文献

关键试剂的特性分析和再评估以确保长期稳定性:两个案例研究。

Critical reagent characterization and re-evaluation to ensure long-term stability: two case studies.

机构信息

Pfizer Inc., BioMedicine Design, One Burtt Road, Andover, MA 01810, USA.

出版信息

Bioanalysis. 2021 May;13(10):807-815. doi: 10.4155/bio-2020-0222. Epub 2021 Apr 22.

Abstract

Characterization of critical reagents can mitigate adverse impact to ligand-binding assay performance. We investigated the conjugation conditions of a bispecific protein to SULFO-TAG NHS-Ester™ ruthenium to resolve a steady increase in ligand-binding assay background signal. Functional and biophysical attributes in stability samples revealed low pH (4.0) conjugation and formulation buffers were key to decrease aggregate formation. We also identified pH-specific (3.0) purification conditions to reduce aggregate levels from 37% to <5% of a mouse IgG3 reagent antibody. These case studies support the utility of biophysical and functional characterization of critical reagents as a proactive approach to maintain long-term stability and provide the basis for our recommendations a risk-based approach to establish re-evaluation intervals for traditional and novel reagents.

摘要

对关键试剂进行特性描述可以减轻对配体结合分析性能的不利影响。我们研究了双特异性蛋白与 SULFO-TAG NHS-Ester™钌的偶联条件,以解决配体结合分析背景信号持续增加的问题。在稳定性样品中的功能和物理属性研究表明,低 pH 值(4.0)的偶联和制剂缓冲液是减少聚集物形成的关键。我们还确定了特定 pH 值(3.0)的纯化条件,可将聚集体水平从小鼠 IgG3 试剂抗体的 37%降低到<5%。这些案例研究支持对关键试剂进行物理化学和功能特性描述,作为一种主动方法来维持长期稳定性,并为我们的建议提供了基础,即采用基于风险的方法来确定传统和新型试剂的重新评估间隔。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验